Dupilumab for patchy hair loss with scalp inflammation
Treatments studied
Part of Skin clinical trials.
This Phase 2 trial tests dupilumab (an injection medicine) to regrow hair in people with alopecia areata, a condition where the immune system attacks hair follicles. It may help by reducing the immune-related inflammation linked to hair loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and able to sign consent and follow study visits.
- You must have alopecia areata (at least 6 months) or nearly all scalp hair loss (alopecia totalis/universalis).
- Your blood tests must meet specific ranges (for blood cells, liver tests, kidney function, and hemoglobin).
- If you can become pregnant, you must have a negative pregnancy test and use reliable birth control during the study and for 28 days after the last dose.
- You must not be pregnant or breastfeeding.
- Your hair loss type must fit alopecia areata, not other likely causes like scarring or traction.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies dupilumab (an injection medicine) to help grow hair in children and teens with alopecia areata, an autoimmune hair-loss condition. It aims to see whether the treatment improves hair regrowth compared with usual care over the study period.
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
This study compares two treatments for patchy hair loss on the scalp: a vitamin D-like cream (calcipotriol) and steroid injections (intralesional steroids). It aims to see which is more effective at regrowing hair in adults with less than half of the scalp affected.
This study tests a pill called baricitinib (a JAK inhibitor) to see if it can stop rapid hair loss and help hair regrow in people with recent, active alopecia areata. It focuses on those who have been shedding hair for less than three months, so it might stop the process earlier than usual.
This trial tests if microneedling with either lactic acid, vitamin D3, or a steroid cream helps regrow hair in people with patchy alopecia areata (small bald spots).
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.